Univ.-Prof. Dr. rer. nat.
Ralf Weiskirchen
Institut für Molekulare Pathobiochemie,
Experimentelle Gentherapie und Klinische Chemie (IFMPEGKC)
RWTH Universitätsklinikum Aachen
Pauwelsstr. 30, D-52074 Aachen, Germany
ORCID
University Link
Short CV
Ralf Weiskirchen is a full Professor and the Head of the Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC) at RWTH University Aachen. He obtained his PhD from the Institute of Biochemistry, Medical Faculty, University of Cologne, in 1994. With a strong academic background and extensive research experience, he has expertise in various biological disciplines, such as molecular biology, microbiology, biochemistry, pharmacology, and genetics. His primary research focus is on understanding the molecular mechanisms involved in the development of hepatic diseases. Specifically, he investigates the immunobiology of the liver, ranging from its healthy state to chronic inflammation, fibrosis, cirrhosis, and cancer. He places special emphasis on studying cytokine/chemokine activities and identifying new laboratory biomarkers for specific conditions. In recognition of his contributions, he was selected for inclusion in the 2024 Highly Cited Researchers list from Clarivate.
Research Interest
Molecular Biology, Biochemistry, Pharmacology, Genetics
• Available methodology
Cell culture techniques, Biomarker identification, immunobiological techniques, histopathological analysis, in vivo Models, Experimental gene therapy approaches, Omics technologies, Exosome isolation, data analysis
Lab Skills
Liver fibrosis, cell signaling pathways, biomarker research, cytokines, chemokines, gene therapy, lipocalins, translational medicine, experimental models of liver disease, pharmacological interventions